Role of Repeat Resection in Non–Muscle-Invasive Bladder Cancer

Restricted access

Repeat transurethral resection (TUR) is indicated for high-grade non–muscle-invasive bladder tumors. Repeat TUR is a diagnostic, therapeutic, prognostic, and predictive procedure. Repeat TUR achieves optimal local control by removing residual tumors after initial TUR, improves staging accuracy, provides additional histologic material favoring accurate diagnosis, allocates appropriate therapy with improved outcomes, facilitates response to intravesical therapy, and provides important prognostic information.

Correspondence: Harry W. Herr, MD, Memorial Sloan Kettering Cancer Center, 353 East 68th Street, New York, NY 10065. E-mail: herrh@mskcc.org
  • 1.

    Herr HW, Donat SM. Quality control in transurethral resection of bladder tumors. BJUI 2008;102:12421246.

  • 2.

    Clark PE, Speiss PE, Agarwal N. NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer. Version 2, 2015. Available at: NCCN.org. Accessed July 15, 2015.

    • Search Google Scholar
    • Export Citation
  • 3.

    Maruniak NA, Takezawa K, Murphy WM. Accurate pathologic staging of urothelial neoplasms requires better cystoscopic sampling. J Urol 2002;167:24042407.

    • Search Google Scholar
    • Export Citation
  • 4.

    Zurkirchen MA, Sulser T, Gaspert A, Hauri D. Second TUR of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists. Urol Int 2004;72:99102.

    • Search Google Scholar
    • Export Citation
  • 5.

    Dalbagni G, Herr HW, Reuter VE. Impact of a second transurethral resection on staging of T1 bladder cancer. Urology 2002;60:822825.

  • 6.

    Pycha Al. How to teach the teacher to teach the TUR-B. Int J Surg 2007;5:8185.

  • 7.

    Richards KA, Smith ND, Steinberg GD. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. J Urol 2014;191:16551664.

    • Search Google Scholar
    • Export Citation
  • 8.

    Herr HW. Role of re-resection in non-muscle-invasive bladder cancer. ScientificWorldJournal 2011;11:283288.

  • 9.

    Vianello A, Costantini E, Del Zingaro M. Repeated white light transurethral resection of the bladder in nonmuscle-invasive urothelial bladder cancers: systematic review and meta-analysis. J Endourol 2011;25:17031712.

    • Search Google Scholar
    • Export Citation
  • 10.

    Guevara A, Salomon L, Allory Y. The role of tumor-free status in repeat resection before intravesical BCG for high grade Ta,T1 and CIS bladder cancer. J Urol 2010;183:21612164.

    • Search Google Scholar
    • Export Citation
  • 11.

    Divrik RT, Sahin AF, Yildirim U. Impact of routine second TUR on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomized clinical trial. Eur Urol 2010;58:185190.

    • Search Google Scholar
    • Export Citation
  • 12.

    Sfakianos JP, Kim PH, Herr HW. The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical BCG. J Urol 2013;191:341345.

    • Search Google Scholar
    • Export Citation
  • 13.

    Dalbagni G, Vora K, Kaag M. Clinical outcome in a contemporary series of restaged patients with T1 bladder cancer. Eur Urol 2009;56:903910.

  • 14.

    Herr HW, Donat SM, Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 2007;177:7579.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 146 114 15
PDF Downloads 73 64 9
EPUB Downloads 0 0 0